LTS is the market leader for TTS and OTF
Since its foundation in 1984, LTS has developed into a strong and innovative medium-sized company. As a global player, LTS is an attractive employer that is aware of its social responsibility and is happy to take it on.
From the initial vision to a leading partner to the pharmaceutical industry
It all started with the vision of a transdermal patch, and has developed into a success story that has lasted to this day: read on for an overview of the history of LTS and its major milestones.
FACTS AND FIGURES
Successful development in 2018
LTS is the global market leader in the development and manufacture of transdermal systems LTS TTS and oral thin films LTS OTF. LTS continued its successful development once again in 2014 and remains on course for further growth.